InvestorsHub Logo
Followers 47
Posts 4683
Boards Moderated 0
Alias Born 07/19/2006

Re: dewophile post# 3042

Tuesday, 07/30/2024 12:07:26 PM

Tuesday, July 30, 2024 12:07:26 PM

Post# of 3181
it looks like less than a day shorter symptom duration even on the restricted 6 symptom endpoint
VL curves do separate, but not by a lot and could be driven by the higher risk patients in the trial versus enanta
certainly based on symptom endpoint edp-235 looks more effective, especially given there were no high risk patients at all included, although I haven't compared the definitions for an apples to apples comparison
I have no idea if this resurrects any partnering prospects for 235
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News